What is the Impact Factor of Translational Neurodegeneration?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Translational Neurodegeneration is 19.1, ranking in quartile Q1 of Web of Science (SCIE).

Is Translational Neurodegeneration indexed in Web of Science or Scopus?

Yes, Translational Neurodegeneration is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 4.992 (Q1) and an H-index of 77.

Who publishes Translational Neurodegeneration and what is the Article Processing Charge (APC)?

Translational Neurodegeneration is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $4,155 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Translational Neurodegeneration?

The official ISO-4 abbreviation of Translational Neurodegeneration is "TRANSL NEURODEGENER" with common acronym "tneu". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #287Top JournalGold OA

Translational Neurodegeneration

Acronym:tneu

•

Abbreviation (ISO):TRANSL NEURODEGENER

•

Identifier (ISSN):2047-9158(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

19.1↑ +3.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Translational Neurodegeneration

WoS Q1

Annual Impact Factor Metric

Current (2026):19.1

Scopus SJR & RankScopus Q1

4.992

#287

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

77 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate0.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

44articles/year

100% Gold OA•52.83% Original Research

Aims & Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Topics Covered (Recognized by AI)

Medicine99.5%Biology99.5%Internal medicine96.3%Pathology92.3%Disease88.3%Psychology87.7%Neuroscience85.1%Psychiatry62.1%Genetics60.3%Chemistry59.2%Biochemistry57.6%Neurology47.2%Parkinson's disease40.3%Endocrinology39.5%Gene34.7%Cell biology28.8%Neurodegeneration22.7%Dementia21.9%Immunology20.5%Bioinformatics20.5%

Primary Research Areas

Neuroscience Cognitive Neuroscience

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

NEUROSCIENCES

Rank6/330

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank9/330

IndexSCIE

Category	Index	Rank	Quartile
NEUROSCIENCES	JCRSCIE	6/330	Q1
NEUROSCIENCES	JCISCIE	9/330	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF19.1

Articles / Year38

Total Citations34

2025

IF15.2

Articles / Year72

Total Citations815

2024

IF10.8

Articles / Year68

Total Citations2,112

2023

IF12.6

Articles / Year59

Total Citations2,878

2022

IF9.883

Articles / Year58

Total Citations4,122

Year	Impact Factor	Articles / Year	Total Citations
2026	19.1	38	34
2025	15.2	72	815
2024	10.8	68	2,112
2023	12.6	59	2,878
2022	9.883	58	4,122
2021	8.014	50	2,686
2020	5.551	45	5,821
2019	5.534	38	2,781
2018	5.872	35	2,398
2017	—	35	3,470
2016	—	24	1,806
2015	—	24	2,861

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #287Scopus Q1SCImago Profile

Scopus Coverage:2012-2026

•

Scopus Broad Areas:MedicineNeuroscience

Scopus Citation Rank (SJR)Q1

4.992

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

15.12

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,155 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,947

3-Year Documents175

Citable Documents153

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cellular and Molecular NeuroscienceQ1

Cognitive NeuroscienceQ1

Neurology (clinical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区NEUROSCIENCES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Translational Neurodegeneration (acronym: tneu, abbr: TRANSL NEURODEGENER, ISSN: 2047-9158) is a peer-reviewed international scholarly journal in the field of Neuroscience, published by BioMed Central in United Kingdom since 2012. The periodical holds a Journal Impact Factor (JIF) of 19.1, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 4.992 (Q1), an H-index of 77.

The journal enforces rigorous peer evaluation with an annual output of approximately 44 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,155 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.